Rheumatoid Arthritis News

Gut microbiota profiles in stool samples of patients with rheumatoid arthritis predicted their response to disease-modifying antirheumatic drugs, according to data in Rheumatology.

Among patients with rheumatoid arthritis diagnosed with breast cancer, the utilization of TNF inhibitors and other biologic disease-modifying antirheumatic drugs has not risen for more than a decade, according to data published in Arthritis Care & Research.

After the passage of the Affordable Care Act, wait times for hand surgery increased among patients with rheumatoid arthritis in rural areas compared with urban patients for whom surgical wait times declined, according to a recent study.

Daily baricitinib, either 4 mg or 2 mg, demonstrates up to 6.5 years of efficacy with low rates of discontinuation due to adverse events in patients with rheumatoid arthritis, according to data published in Rheumatology.

Men with inflammatory joint diseases have more children and are less likely to be childless, compared with those without inflammatory joint diseases, according to data published in the Annals of the Rheumatic Diseases.

A lot can change in a year. But has it?

The mission to understand rheumatoid arthritis inflammation at a molecular level has gained momentum with the rapid evolution of cutting-edge technologies, allowing researchers to delve deeper into the individual differences in inflammatory subtypes.

Just as the groundhog reappears each year to make its forecast, Feb. 2 also brings a renewed focus on rheumatoid arthritis and its impact on the daily lives of millions of Americans.

Celltrion USA has submitted a Biologics License Application to the FDA for its tocilizumab biosimilar candidate CT-P47, according to a press release.

An initiative to switch clinically stable patients from Remicade to a biosimilar significantly increased biosimilar use in rheumatology and gastroenterology clinics within the University of North Carolina health system, according to data.